INFLUENCE OF PHARMACISTS' INTERVENTION ON DRUG-RELATED PROBLEMS RELATED TO CHANGE IN HEMOGLOBIN LEVELS OF HEMODIALYSIS PATIENTS AT ADJIDARMO HOSPITAL, LEBAK, BANTEN

Ai Yeni Herlinawati; Rani Saurisari; Retnosariandrajati Retnosariandrajati

doi:10.22159/ajpcr.2017.v10s5.23113

Authors

Ai Yeni Herlinawati Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
Rani Saurisari Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
Retnosariandrajati Retnosariandrajati Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10s5.23113

Keywords:

Hemoglobin, Drug-related problem, Hemodialysis

Abstract

Â

Â Objective: This study aims to evaluate the intervention of pharmacists for drug-related problems (DRPs) related to hemoglobin (Hb) level.

Methods: This study uses a prospective pre-experimental and pre-post design. The study sample included 85 patients. All patients were interviewed, and their prescriptions were identified. Then, interventions were given to doctors and patients based on the identified DRPs. Univariate, bivariate, and multivariate data analysis with binary logistic regression analysis were used.

Results: There was a significant decrease (p<0.05) in the number of DRPs before (2.85Â±1.82) and after (0.74Â±0.86) the intervention. There was also a significant increase (p<0.05) in the average Hb level before (9.29Â±1.39) and after (9.68Â±1.41) the intervention; the average increase in Hb level after the intervention was 0.39 g/dl. DRP significantly influences the changes in Hb level after the intervention. Hb level increased by 0.145 times after intervention (odds ratio=0.145, p=0.015).

Conclusions: Pharmacists' intervention for DRPs can increase the success of anemia therapy of hemodialysis patients at Adjidarmo Hospital, Lebak, Banten.

Downloads

Download data is not yet available.

References

Price SA, Wilson LM. Pathophysiologi: Chlinical Concept of Disease Process. New York: McGraw-Hill; 2006.

De Benoist B, McLean E, Egly I, Cogswell M, editors. Worldwide Prevalence of Anaemia 1993-2005: WHO Global Database on Anaemia World Health Organization. Geneva: World Health Organization; 2008.

Taal MW. Progress in risk prediction for people with chronic kidney disease. Curr Opin Nephrol Hypertens 2014;23(6):519-24.

Perhimpunan Nefrologi Indonesia. Konsensus Manajemen Anemia Pada Penyakit Ginjal Kronik. 2nd ed. Jakarta: Perhimpunan Nefrologi Indonesia; 2011.

Rani NV, Thomas R, Rohini E, Soundararajan P, Kannan G, Thennarasu P, et al. A study on drug related problem in chronic kidney disease patients of tertiary care teaching hospital in South India. Faculty of Pharmacy. Chennai, India: Sri Ramachandra University; 2014.

Pharmaceutical Care Network Europe (PCNE) Foundation. PCNE Classification for Drug Related Problems. Vol. 6. PCNE; 2010. p. 2.

Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacistsâ€™ interventions in the management of patients with chronic kidney disease: A systematic review. Nephrol Dial Transplant 2012;27(1):276-92.

Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol 2008;102(3):275-80.

Gulec S, Anderson GJ, Collins JF. Mechanistic and regulatory aspects of intestinal iron absorption. Am J Physiol Gastrointest Liver Physiol 2014;307(4):G397-409.

Lacy CF, Armstrong LL, Goldman MP, Lance LL. Lexi-Compâ€™s Drug Information Handbook 2010-2011: A Comprehensive Resource for All Clinicians and Healthcare Professionals. 19th ed. Hudson: Lexi-Comp; 2010.